Entera Bio (ENTX) Stock Highlights

2.1 | -2.78%

2024-12-21 07:08:55

Entera Bio Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with significant unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The companys product candidates, EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are in clinical development. The company recently completed the phase 2 study for EB613. The company also licenses its technology to biopharmaceutical companies for use with their proprietary compounds and, to date, has established a collaboration with Amgen Inc.

Statistics

Range Today

2.08 2.21

Volume Today 65.2K

Range 1 Year

0.52 3.35

Volume 1 Year 30.25M

Range 3 Year

0.47 3.51

Volume 3 Year 71.74M

Range 10 Year

0.47 10.16

Volume 10 Year 913.28M

Highlights

Market Capitalization 62.48M (small)

Floating Shares 25.5M

Current Price 2.1

Price To Earnings -6.81

Price To Revenue 943.09

Price To Book 7.32

Earnings Per Share -0.26

Payout Ratio 0%

Performance

Latest -2.78%

1 Month +25.75%

3 Months +3.45%

6 Months +2.44%

1 Year +208.82%

3 Years -31.82%

5 Years +6.6%

10 Years -71.23%

Benchmarks

Market Capitalization

309 / 368

Gross Profits

150 / 278

Total Revenue

283 / 300

Total Rank

117 / 368

Free Cashflow

59 / 352

Performance 5 years

111 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.